A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study

Geoffrey Herkes, Claire McGee, Ann Liebert, Brian Bicknell, Vivian Isaac, Hosen Kiat, Craig S McLachlan · 2023

Read A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study by Geoffrey Herkes, Claire McGee, Ann Liebert, Brian Bicknell, Vivian Isaac, Hosen Kiat, Craig S McLachlan (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716000.txt.

Description

Herkes and co-authors test a helmet that shines red and infrared light through the skull as a possible help for Parkinson's disease. Light therapy, called photobiomodulation, had shown promise in animals and a small case series. This trial asks the practical questions first: is home treatment safe, and can patients stick with it?

Forty patients were randomly assigned to an active or a sham helmet for twelve weeks, with sessions six days a week at home, watched over video calls. Nearly everyone finished, and side effects were minor and brief. Some then crossed over to active treatment for another twelve weeks. The authors conclude the approach is safe and feasible, setting up larger trials of benefit.

Catalog record

CREATORGeoffrey Herkes, Claire McGee, Ann Liebert, Brian Bicknell, Vivian Isaac, Hosen Kiat, Craig S McLachlan
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10716000

Browse the full library · About the Tower of Babel